Ads
related to: fda, pharmaceuticalsthomasnet.com has been visited by 10K+ users in the past month
Search results
Vanda Pharmaceuticals Receives Another Takeover Proposal, Considers $466M Deal - Vanda Pharma...
Benzinga· 19 minutes agoIn May, Cycle launched its sixth drug product in the U.S. market. In April, Vanda rejected Future Pak LLC’s proposal of $7.25 – $7.75 per share, saying it significantly undervalued the company ...
Cheaper Ozempic Alternatives Are Out There. Be Wary of Fakes and Fraudsters.
The Wall Street Journal· 4 hours agoMillions of people are taking Ozempic, Wegovy or Mounjaro for weight loss. Compounded drugs are...
Ani Pharmaceuticals CFO sells shares worth over $317k By Investing.com
Investing.com· 5 hours agoANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has reported a significant transaction involving its Senior...
Vanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY®
The Sun Chronicle· 7 days agoVanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that ownership of the U.S. New Drug ...Company, which now fully allows Vanda to commercialize PONVORY® in ...
MDMA-Maker Failed Its FDA Hearing — And Its PTSD Patients
Bloomberg· 1 day agoLykos Therapeutics showed up to a regulatory hearing woefully unprepared. Lisa Jarvis is a Bloomberg...
Jazz Pharmaceuticals stock maintains Outperform rating By Investing.com
Investing.com· 5 hours agoOn Thursday, RBC (TSX:RY) Capital Markets sustained its Outperform rating and $176.00 price target...
Why Is Rocket Pharmaceuticals (RCKT) Down 4.8% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 day agoWill the recent negative trend continue leading up to its next earnings release, or is Rocket ...
Tapinarof may mark Dermavant’s first atopic dermatitis approval
Clinical Trials Arena via Yahoo Finance· 5 hours agoThis marks a milestone for Dermavant, as it is one step closer to market authorisation for their...
Robert Kennedy Jr. Is Sorry the FDA Didn't Approve Psychedelic Drug MDMA (Ecstasy or Molly) for PTSD...
Showbiz411· 16 hours agoWhat is our potential next president worried about? Robert Kennedy Jr — just kidding– never to be...
EXCLUSIVE: Adial Pharmaceuticals Starts Patient Dosing In Pharmacokinetics Study Of AD04 For Alcohol...
Benzinga via Yahoo Finance· 1 day agoWednesday, Adial Pharmaceuticals Inc. (NASDAQ:ADIL) announced that the first patient had been dosed...